DOCK2 and non-small cell lung carcinoma: The majority of mutations for ABR, PREX1, DOCK2, and DOCK4 in NSCLC are missense and truncating mutations, which means a change of a single amino acid into another and a change in the DNA that can shorten the protein, respectively.